科学图书馆
-
Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National RegistryKhazanie P, Hellkamp AS, Hernandez AF et al. -
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionMcMurray JJV, SD Solomon, DAPA-HF Committees and Investigators.
-
Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?P Z Maslov, JK Kim, E Argulian et al.
-
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart FailureB Bozkurt, AJS Coats, H Tsutsui et al.
-
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart FailureMcMurray JJ, Krum H, ATMOSPHERE Committees Investigators.
-
Association of Cardiovascular Disease With Respiratory DiseaseP Carter, J Lagan, C Fortune et al.
-
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?G Gulat, JE Udelson.
-
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)McMurray JJV, DeMets DL, DAPA-HF Committees and Investigators.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
